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Scheme S1. Synthesis of 6, . 6,6'-Dimethyl-3,3'-bipyridine: [S1] A mixture of 5-bromo-2-methyl-pyridine (1.37 g, 8 mmol), Pd(OAc) 2 (90 mg, 0.4 mmol), K 2 CO 3 (1.10 g, 8 mmol), tetra-n-butylammonium bromide (1.29 g, 4 mmol) in DMF (0.9 mL)/H 2 O (0.35 mL) was stirred at 115 °C under argon for 2 minutes. Isopropanol (480 mg, 8 mmol) was added. After stirring for 48 h, the reaction mixture was allowed to cool down to room temperature. The mixture was added water and ether, and the organic phase was separated, washed with brine, and dried over anhydrous Na 2 SO 4 . The solvent was then evaporated under reduced pressure and the residue was purified by silica gel column chromatography to afford the desired was employed along with a reduced preactivation time (0.5 min) in order to minimize racemization. 
S4
The Fmoc deprotection was accomplished by treating the peptide-bound resin with 20% piperidine/DMF (3×, 8 min each). After the amino acids were assembled, the N-terminal amine was acylated using 10 equiv of acetic anhydride and 10 equiv of DIEA. The peptides were then cleaved by treating the resin with a cleavage cocktail containing 95% TFA, 2.5% ethane dithiol, 1.5% triisopropylsilane and 1% water for a period of 1.5 hr (extended to 2.5 hr for peptides containing Pbf protecting groups). The peptides were precipitated in diethyl ether, collected by centrifugation, and washed with diethyl ether prior to drying in high vacuum. The crude peptides were purified by Gilson reverse-phase HPLC equipped with a semi-prep Phenomenex C18 column running at a flow rate of 5 mL/min and a gradient of 10-90%
acetonitrile/H 2 O containing 0.1% TFA. Fractions with greater than 90% purity were pooled and lyopholized to give the desired peptides. buffer, pH 8.5 (1:4 to 2:3 depending on peptide solubility) to obtain a final peptide concentration of 1 mM. The mixture was stirred at room temperature for 1.5-2 hours. Afterwards, the solvents were evaporated and excess amount of cross-linker was removed by washing the residue with diethyl ether.
The cross-linked peptides were then purified by preparative HPLC.
Langevin Dynamics:
The distance distributions of Bph and Bpy cross-linkers were calculated using Langevin dynamics simulations. The S-methylated cross-linkers were used in this simulation and their structures were shown on the top. The distance between the two sulfur atoms was monitored throughout the simulation. The langevin dynamics simulation was carried out with Hyperchem 8.0. The structures were minimized using Amber 99 force field prior to dynamics simulation. The simulation wsa set up to last 1000 ps with 1-ps timestep at 300 K. A unimodal distributions were observed when the number of conformations was plotted to the S-S distance. The median S-S distances for both cross-linkers stand around 11.6 Å. with either Bph or Bpy. The identities of each individual peaks were confirmed by electrospray mass spectrometry (see Table S1 ).
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ELISA Assay: GST-Mdm2 and GST-Mdmx containing full-length human Mdm2 and Mdmx and His 6 -tagged human p53 were expressed in E. coli and purified by glutathione agarose and Ni 2+ -nitrilotriacetic acid beads, respectively, under non-denaturing conditions. Microtiter plates were coated with 2.5 μg/ml His 6 -p53 in PBS buffer for 16 hr. After washing with PBS containing 0.1% Tween-20 (PBST), the plates were blocked with PBST containing 5% nonfat dry milk (PBSTM) for 30 min. Peptides were dissolved in DMSO. GST-Mdm2 and -Mdmx (5 μg/ml) were mixed with peptides in PBSMT containing 10% glycerol and 10 mM dithiolthreitol prior to their additions to the wells at specified concentrations. The incubation was allowed to proceed for 1 hr at room temperature before the plates were washed with PBST. The plates were then incubated with either anti-Mdm2 antibody 5B10 or anti-Mdmx antibody 8C6 in PBSTM for 1 hr, followed by washing with PBST and incubation with horseradish peroxidase-conjugated rabbit anti-mouse Ig antibody for 1 hr. The plates were developed by incubation with TMB peroxidase substrate (KPL, Gaithersburg, MD) and measured the absorbance at 450 nm. The data was analyzed with the Origin 6.0 software (Fig. S3) 1800 ± 180 nM 4800 ± 1100 nM 890 ± 120 nM 5500 ± 980 nM 1500 ± 150 nM 340 ± 27 nM 22 ± 4.0 nM 14 ± 2.0 nM 4500 ± 890 nM 1200 ± 87 nM Log(nM) 
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Molecular Modeling Studies of 3b:
The cordinates for PDI complexed with MDMX was obtained from the PDB Code: 3FDO. [S3] Two L-Cys substitutions were introduced to replace Glu-4 and Thr11 of PDI and the resulting peptide 1 was energy-minimized using the Amber 99 force field in Hyperchem 8 to produce a model of MDMX-bound 1 (a). Similarly, L-cys at position 4 of peptide 1 was replaced with Dcys, and the resulting peptide 3 was energy-minimized to generate MDM-bound 3 (c). Separately, Bpy cross-linker was constructed and energy-minimized initially before connecting to sulfhydryl groups of the cystienes to generate peptides 1b and 3b. Then, the cross-linked peptide-MDMX complexes were subjected to complete energy minimization in Hyperchem 8. The optimized complex structural models were shown in (b) and (d). 
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FACS Analysis: HeLa Cells were cultured in DMEM medium supplemented with 10% fetal bovine serum in 6-well plate in a 37 ºC, 5% CO 2 incubator to reach confluency of around 70%. Cells were then washed twice with PBS before switching to serum-free DMEM medium. After standing in the incubator for 30 min, appropriate amounts of peptides (1 mM in DMSO) were added to the culture plate to obtain a final peptide concentration of 10 µM. Cells were incubated at 37ºC for additional 2 hours. Then medium was removed and cells were washed with PBS (3×) followed by treatment with trypsin to detach the cells.
After a brief low-speed centrifugation, HeLa cells were collected and re-suspended in PBS for the FACS analysis. Confocal Microscopy: HeLa Cells were seeded into 35 mm glass bottom microwell dishes (MatTek, Ashland, MA) at a density of 3 × 10 5 in DMEM medium supplemented with 10% fetal bovine serum, and the cells were allowed to grow in a 37ºC 5% CO 2 incubator for 48 hours. After removing medium, cells were washed twice with PBS and then incubated in serum-free DMEM medium for 30 min. Appropriate amounts of peptides (1 mM in DMSO) were then added to obtain a final concentration of 10 µM and cells were incubated at 37ºC for 2 hours. After PBS wash, cells were treated with 4% formaldehyde in PBS for 20 min at room temperature. The fixation medium was removed and the cells were washed with PBS (3×) before placed into the low florescent mounting medium for fluorescent imaging acquisition.
Circular Dichroism
Live Cell Confocal Microscopy: HeLa cells were cultured in a 35-mm glass bottom microwell dish as described previously. The cells were incubated with peptide 3b for 2 hours in a serum-free medium followed by addition of a 40 µL solution containing 500 µg/mL of Alexa Fluor 586-labeled transferrin (Invitrogen, Carlsbad, CA) and 1.5 µM Hoescht 33342 dye and additional incubation for 30 min.
Afterwards, cells were washed with PBS and placed into Earle's balanced salt solution supplemented with MEM essential and non-essential amino acids. All images were taken with a Zeiss LSM-510 meta-NLO system equipped with a Coherent Chameleon Ultra II Ti/Sapphire laser and external non-descanned detectors.
Luciferase Reporter Assay: PA1 cells stably expressing the p53-responsive reporter BP100-Luc were maintained in DMEM medium supplemented with 10% FBS. PA1-BP100 cells (~50,000) were seeded into 24-well plates and treated with 0 -200 μM peptide 3, 3b, or 0 -10 μM nutlin-3 in DMEM medium supplemented with 10% FBS for 16 hours. Cells were lysed and luciferase activity was determined. 
